BIM
RIGL icon

Bogle Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bogle Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,744
Closed -$724K – 393
2016
Q3 		$724K Sell
19,744
-1,522
-7% -$43.6K 0.05% 277
2016
Q2 		$474K Sell
21,266
-9,279
-30% -$231K 0.03% 323
2016
Q1 		$635K Sell
30,545
-139
-0.5% -$3.43K 0.04% 311
2015
Q4 		$929K Sell
30,684
-4,181
-12% -$127K 0.07% 274
2015
Q3 		$861K Sell
34,865
-19,482
-36% -$581K 0.06% 272
2015
Q2 		$1.74M Buy
+54,347
New +$2.08M 0.13% 201
2014
Q3 		– Sell
-7,143
Closed -$259K – 392
2014
Q2 		$259K Buy
+7,143
New +$243K 0.02% 307

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Bogle Investment Management's RIGL Position: Q4 2016 in Review

Bogle Investment Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2016, closing a stake of 19,744 shares — an estimated $724K sold.

Bogle Investment Management first reported a position in RIGL in Q2 2014 and held it in 7 quarters. The position peaked at $1.74M in Q2 2015. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • Bogle Investment Management reported no remaining Rigel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Bogle Investment Management sold 19,744 Rigel Pharmaceuticals shares in Q4 2016, an estimated $724K.
  • Bogle Investment Management first reported a position in Rigel Pharmaceuticals in Q2 2014 and held it in 7 quarters.
  • Bogle Investment Management's Rigel Pharmaceuticals position peaked at $1.74M in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on Bogle Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.